These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4828627)

  • 21. Relationship between serum lithium level and clinical response to depression treated with lithium carbonate.
    Watanabe S; Ishino H; Fujiwara J; Otsuki S
    Folia Psychiatr Neurol Jpn; 1974; 28(3):167-77. PubMed ID: 4611875
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium absorption from sustained-release tablets (Duretter).
    Amdisen A; Sjögren J
    Acta Pharm Suec; 1968 Nov; 5(5):465-72. PubMed ID: 5732567
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group.
    Prien RF; Caffey EM; Klett CJ
    Arch Gen Psychiatry; 1972 Aug; 27(2):182-9. PubMed ID: 5042825
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the use of blood lithium concentrations in lithium therapy in Japan.
    Shimizu M; Sakaue N; Kaito T; Ikeda R
    Int Pharmacopsychiatry; 1979; 14(3):170-5. PubMed ID: 521241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side effects of a "sustained release" lithium preparation.
    Persson G
    Acta Psychiatr Scand Suppl; 1971; 221():33-8. PubMed ID: 5286326
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indications for lithium not including manic-depressive psychoses].
    Deniker P; Ginestet D; Colonna L; Lôo H
    Ann Med Psychol (Paris); 1972 Feb; 1(2):260-3. PubMed ID: 5051255
    [No Abstract]   [Full Text] [Related]  

  • 28. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experimentation with lithium carbonate retard].
    Burton P
    Rev Med Liege; 1975 Feb; 30(3):79-80. PubMed ID: 1162210
    [No Abstract]   [Full Text] [Related]  

  • 30. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage.
    Thornhill DP
    Eur J Clin Pharmacol; 1978 Dec; 14(4):267-71. PubMed ID: 365541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
    Johnson GF; Hunt GE; Lewis J; St George B
    Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group.
    Prien RF; Caffey EM; Klett CJ
    Arch Gen Psychiatry; 1973 Mar; 28(3):337-41. PubMed ID: 4569674
    [No Abstract]   [Full Text] [Related]  

  • 34. [Administration of a slow-acting lithium preparation (preliminary report)].
    Molchan I; Motylova A; Khalabala I
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1241-3. PubMed ID: 899543
    [No Abstract]   [Full Text] [Related]  

  • 35. Sustained-release lithium carbonate in double-blind study: serum lithium levels, side effects, and placebo response.
    Marini JL; Sheard MH
    J Clin Pharmacol; 1976; 16(5-6):276-83. PubMed ID: 1262538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of long-acting lithium carbonate--micalite--in the treatment of affective psychoses].
    Khvilivitskiĭ TIa; Mikhalenko IN; Zlatikina GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(4):583-7. PubMed ID: 868433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood levels and management of lithium treatment.
    Crammer JL; Rosser RM; Crane G
    Br Med J; 1974 Sep; 3(5932):650-4. PubMed ID: 4425791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liberation of lithium from sustained release preparations. A comparison of seven registered brands.
    Heim W; Oelschläger H; Kreuter J; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1994 Jan; 27(1):27-31. PubMed ID: 8159780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with poor response to lithium carbonate: a clinical study.
    Aronoff MS; Epstein RS
    Am J Psychiatry; 1970 Oct; 127(4):472-80. PubMed ID: 4918114
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacokinetic properties of the delayed-action form of lithium carbonate].
    Kabes J; Kabesová L
    Cesk Psychiatr; 1983 Apr; 79(2):102-6. PubMed ID: 6407766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.